Abbott noted that the Amplatzer Piccolo, a device even smaller than a small pea, now offers hope to premature infants and newborns who need corrective treatment, and who may be non-responsive to ...

Explore how Abbott is transforming cardiovascular care through AI, minimally invasive devices, and digital health ...

Results reinforce that Amplatzer Piccolo™ Occluder is safe and effective for closing an opening in the heart known as a "patent ductus arteriosus" (PDA) in newborns Study found low adverse event ...

Results reinforce that Amplatzer Piccolo™ Occluder is safe and effective for closing an opening in the heart known as a "patent ductus arteriosus" (PDA) in newborns Study found low adverse event rates ...

ABBOTT PARK, Ill., Sept. 8, 2022 /PRNewswire/ -- Abbott (NYSE: ABT) today announced three-year data showing the positive impact of the Amplatzer Piccolo™ Occluder on treating babies (some ...

Abbott's Amplatzer Piccolo Occluder is a wire mesh device inserted through an incision in the leg, then guided through blood vessels until it reaches the PDA site in the heart. It thus closes the ...

In Abbott’s clinical trial for the Aveir DR pacemaker, the results for which were published in the New England Journal of Medicine, 295 patients were implanted with the device.